The situation of gynecological cancers in Thailand: incidence, histopathology, and survival outcomes from national cancer registry data
Year: 2025
Type: article
Study design: Observational Study
Abstract: OBJECTIVE: Cervical, uterine, and ovarian cancers are the 3 main cancers of the female reproductive system. Analyzing data from the cancer registry database will help understand the situation and trends of these diseases. METHODS: This study utilized data from Thailand's population-based cancer registries covering 16 provinces across 5 geographic regions between 2019 and 2021. Data collection included demographic characteristics, cancer incidence, histopathology, disease stage, and survival outcomes. Incidence rates were calculated using age-standardized rates (ASRs) per 100,000 population, and 5-year survival outcomes were compared across 2 time periods (2013-2017 vs. 2018-2022). RESULTS: During 2019-2021, Thailand recorded a mean annual ASR of 132.9 for females, with cervical cancer remaining the most common gynecologic cancer. The incidence of cervical cancer decreased from 19.5 per 100,000 in 1995-2000 to 10.3 per 100,000 in 2019-2021. Uterine cancer demonstrated a rising trend, from 3.6 per 100,000 in 2004-2006 to 6.1 per 100,000 in 2019-2021, while ovarian cancer incidence remained relatively stable at 5.9 per 100,000. Five-year survival rates improved significantly across all gynecologic cancers in 2018-2022 compared with 2013-2017. The hazard ratios for overall survival by stage ranged from 0.57 to 0.81 for cervical, 0.53 to 0.82 for uterine, and 0.57 to 0.81 for ovarian cancers (all p<0.05). CONCLUSION: The incidence of cervical cancer in Thailand has declined over the past 2 decades, while the burdens of uterine and ovarian cancers are increasing. Five-year survival rates have significantly improved across all gynecologic cancer types.
Source: Journal of Gynecologic Oncology
Institutions: National Cancer Institute of Thailand, MedPark Hospital
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
Funder: National Cancer Institute
OpenAlex ID: W4417523886
